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Introduction
The United Nations High Commission for Refugees (UNHCR) has estimated that over 40 mil-
lion people [1] are currently displaced and have variable access to health care in the country in
which they reside. Populations displaced by conflict are largely disenfranchised, and high prev-
alence of neglected tropical diseases (NTDs) has been documented [2]. NTDs generally affect
the least advantaged people in poor societies—populations with little voice or representation.
These already susceptible people become even more vulnerable when forced from their com-
munities as internally displaced persons (IDPs), refugees, or forced migrants. To further com-
plicate matters, many of these people of concern are under 18 years old. Children experience
the greatest risk and suffer the most consequences of NTDs. As marginalized populations flee
from conflict or environmental catastrophe, they are often burdened with insidious NTDs
ranging from asymptomatic to overt and debilitating disease. Many suffer from chronic conse-
quences such as malnutrition, growth stunting and developmental delays, inhibiting chances
for sustainable livelihoods and making it less likely that they will successfully overcome the ad-
versity of displacement.
The World Health Organization (WHO) has defined 17 key neglected diseases, but several
others exist [3]. These diseases are highlighted in Millennium Development Goal (MDG) 6,
which aims to combat HIV/AIDS and “other diseases,” of which the NTDs are discussed at
length [4,5]. It is the intent of these authors to raise the awareness of readers, and argue that
inclusion of these displaced populations in preventive chemotherapy (PCT) programs and
multi-model community-based interventions is not only necessary for sustained success of
NTD control but is also a moral imperative.
Background
Evidence for the association between poverty and NTDs is well documented [3], as is the evi-
dence that human civil conflict, such as war, interrupts infectious disease control and creates
opportunities for transmission and outbreaks [2]. However, the impact of human displacement
on the epidemiology of NTDs amenable to PCT is lacking. However, it is clear even from the
sparse literature that NTD epidemiology is affected by human displacement. Saker et al. men-
tion the appearance of the first human African trypanosomiasis (HAT) cases in southern
Ghana owing to population movement [6]. In addition, Louis et al. describe HAT being
brought to the suburbs of Kinshasa, Democratic Republic of Congo (DRC), by people fleeing
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war in HAT endemic provinces [7]. These are just a couple of concrete examples and this pat-
tern is undoubtedly replicated with many NTDs, particularly those that, like most helminthic
infections, do not need specific vectors [8]. Aagaard et. al eloquently argue that human migra-
tion is a major factor in the introduction, and re-introduction, of NTDs [2]. The risk for NTD
expansion is greatest when displaced populations are forced to set up temporary living situa-
tions where sanitation is inadequate. Displaced populations frequently reside in warm and
humid environments, and the combination of poor sanitation in a hospitable climate creates a
ripe environment for spread of many NTDs. These conditions are generally exacerbated since
displaced populations frequently lack access to health care through national public health pro-
grams (e.g., immunization programs, PCT, established community-based interventions).
Why Are Displaced Populations Frequently Excluded from
Integrated NTD Control Programs?
The current integrated NTD control programs are supported by multiple partners (e.g., USAID,
pharmaceutical industry, WHO) and have been tremendously successful, reaching more than 1
billion people worldwide. However, these programs are successful in some locations and falter
in others, and this relates to local dynamics and issues with population movement, changing
food supply, and relationships between drug distributors and targeted groups [8]. Displaced
populations are frequently excluded from host government integrated control programs. The
majority of programs are coordinated and run through the Ministries of Health (MOH) at the
country level. Ministries and public policy makers are faced with limited funds and will general-
ly focus on established priorities and spend resources on their own native population/constitu-
ents. This occurs due to structural barriers. For example, there is little incentive for country
ministries to spend their limited resources on displaced populations since they are considered
temporary, are often viewed as “irregular,” and often lack legal status and political voice.
Displaced Populations, NTDs, and the International Health Agenda
Evaluating disease burden in displaced populations and understanding the barriers to program
intervention are crucial in guiding evidence based policy decisions to better reach these popula-
tions in the future. Despite the many political, logistical, and ethical barriers to conducting
NTD programs, surveillance, and research in conflict regions, or in countries where “unwel-
come” refugees reside, there exists an urgent need. Although limited, the existing data suggest
very high burdens of NTDs in displaced populations [9,10]. For those working in the NTD
community, the largely inadvertent exclusion of displaced populations needs to be of para-
mount concern since mobile populations present a threat to successful control and elimination
of NTDs in resident populations. As a documented example, malaria elimination programs
have been seen to struggle with success because of failure to address population mobility and
migration [11] and it goes without saying that this same struggle exists in treating NTDs.
It is important to recognize that although there are few programs that systemically reach
displaced populations, there are organizations and agencies, such as the International Organi-
zation for Migration (IOM), who are interested, capable, and willing to distribute and monitor
NTD programs. Unfortunately, because of the current structure of NTD programs, many orga-
nizations have difficulty obtaining drugs or the managerial support necessary for implementing
effective Mass Drug Administration (MDA) programing [12]. There are many small-scale pro-
grams carried out by organizations serving refugee populations (e.g., small non-governmental
organization (NGO) programs) but these are frequently not sustainable, and tend to be focal,
intermittent and often not coordinated with the larger NTD control initiatives. The United
States program for refugee resettlement operates a relatively large-scale program addressing
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refugee populations resettling to the US. However, this is a unique program since it is specifi-
cally aimed at refugees in the US resettlement pipeline and is moving refugees from endemic to
non-endemic settings. Although this program reaches more than 50,000 refugees annually, this
accounts for less than 1% of the worlds displaced population.
Partnering between the NTD community and organizations serving these displaced popula-
tions would be mutually beneficial by creating opportunities to expand existing programing,
and would further serve the goal of NTD control and elimination in resident communities.
Collaboration would benefit the larger NTD community by allowing access to this unique pop-
ulation, providing the opportunity to answer questions that are difficult to answer in endemic
environments. For example, treating refugees who are moving from endemic to non-endemic
areas allows measurement of effectiveness of treatment (drugs and regimens) for specific NTD
organisms—efficacy data that is still largely unknown. Furthermore, collaboration would create
an opportunity to develop tools for the measurement of the impact and control of specific
pathogens. The movement to non-endemic areas creates an opportunity to identify biologic
markers of active infection that could subsequently be used to monitor the success of control in
endemic areas. In addition, novel programing providing US-bound refugees with pre-migra-
tion PCT to treat strongyloidiasis represents an opportunity for the larger MDA community to
evaluate the benefits of presumptive treatment for this particular potentially fatal pathogen.
Furthermore, collaboration would be an act of compassion by providing displaced populations
with greater access to treatment and control programs.
Treatment and Control Programs for Refugees Are the Right Thing
to Do and There Are Steps to Take
It must not be forgotten that the right to health is a basic human right. The human rights con-
ventions provides a policy framework from which to advocate for more research in this area,
legal tools for member state accountability, and platforms for action on global initiatives, such
as the Millennium Development Goals. Specifically, the right to health as defined by Article 12
of the 1976 International Covenant on Economic, Social and Cultural Rights, part C is applica-
ble to NTDs. As of January 2014, 168 of the 192 United Nations member states were party to
the Covenant [13]. Finally, the Convention Relating to the Status of Refugees establishes a prin-
ciple of equity whereby hosting countries should provide refugees with a similar standard of
medical care to that which is routinely available to host nationals [14,15].
WHO and other international organizations have a moral obligation to use the human rights
platform to advocate for expanded treatment programs and for the provision of essential ser-
vices to displaced populations. One current barrier is that the donor pharmaceutical companies
have restricted distribution of medications to MOH. Therefore, non-MOH entities, such as
NGOs like IOM, operating outside the current system, are generally forced into purchasing
medications at market rates. WHO could advocate for a small proportion of donor medication
to be allowed to be distributed through other partners (e.g., UNHCR, NGOs such as the Inter-
national Rescue Committee or Medecins Sans Frontieres). The global health agenda should also
encourage collaboration between the more experienced partners (e.g., WHO/USAID) and these
other non-MOH organizations to implement sustainable integrated control programs [5,16].
MDGs and the Elimination of Certain NTDsWill Not Occur Unless
These Populations Are Reached; Human Displacement Is an
Achilles Heel
NTD treatment for displaced populations should be a priority for the global health agenda. In-
clusion of these populations would decrease health disparities, increase the human right to
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health, and ultimately benefit the ongoing control and eradication efforts of these insidious dis-
eases, as called for in MDG 6. As long as conflict continues and displaced people are excluded
from government-led initiatives, NTD programs will struggle due to remaining pockets of on-
going transmission, introduction, and re-introduction of infection. Elimination of this dispari-
ty in disease burden is contingent upon addressing inequities in access to available medications
and systematic programing. Although we have the tools, increased awareness of the exclusion
of these populations and collaborative partnerships and political will is needed.
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